Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by BlackRock
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.8M | 7.0M | 1.41 |
| 2025-06-30 | $20M | 18M | 1.14 |
| 2025-03-31 | $76M | 60M | 1.28 |
| 2024-12-31 | $13M | 12M | 1.08 |
| 2024-09-30 | $16M | 13M | 1.19 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1